Mayo Clinic Talks COVID-19 Miniseries Episode 31: The Safety of Convalescent Plasma

Mayo Clinic Talks

Mayo Clinic Talks Podcast #166

COVID-19 Miniseries Episode 31: The Safety of Convalescent Plasma

Registration required for CME credit

 

Listen on Apple Podcast  Listen on Google Play Music  Listen on Spotify

You can also listen through your favorite podcast platform:
Apple Podcasts | Google Play Music | Stitcher | Spotify


COVID-19 information evolves daily.  The views and perspectives shared in these resources are presented based on information available at the time of recording.
Recorded May, 2020

For the most up to date information visit:

CDC - Information for Healthcare Professionals about Coronavirus (COVID-19)
World Health Organization's Country & Technical Guidance - Coronavirus disease (COVID-19)
AskMayoExpert COVID-19 Navigator
COVID-19 Online Education, Resources and Updates

Guest: Michael J. Joyner, M.D.
@DrMJoyner
Host: Amit K. Ghosh, M.D., M.B.A.
@AmitGhosh006


Convalescent plasma as a passive immunity strategy is not new. What nuances apply for it’s application to treating COVID-19? Is it safe? Is it efficacious? Dr. Michael Joyner, Principal Investigator for Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19, discusses what’s known about this treatment option, information that’s currently being gathered, and how you can get involved.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

 

Target Audience

This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants

Learning Objectives

Upon completion of this Mayo Clinic Talks podcast episode, learners should be able to:

  • Recall the role of convalescent plasma as a passive immune strategy for COVID-19
  • Recall observed signals of safety from the first 5000 patients indicating TACO and TRALI incidence is not higher than expected from transfusion of convalescent plasma to patients with COVID-19
  • Recall hopes to develop hyperimmune globulin therapy potentially for treatment and prophylaxis

 

Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit
  • 0.25 Attendance
Course opens: 
05/22/2020
Course expires: 
12/29/2022
Cost:
$10.00

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA

Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Available Credit

  • 0.25 AMA PRA Category 1 Credit
  • 0.25 Attendance

Price

Cost:
$10.00
Please login or register to take this course.

Thank you for joining us!  

Everything you need to complete this course is listed in the Course Progress column on this page's left-hand side.  This handy checklist has all of the course components needing completion.  Do them in any order, but completion of all is required for credit.
 

For cancellation details, contact cme@mayo.edu